Your browser doesn't support javascript.
loading
Kinsenoside alleviates oxidative stress-induced blood-brain barrier dysfunction via promoting Nrf2/HO-1 pathway in ischemic stroke.
Qiao, Nan; An, Zhaohong; Fu, Zeyu; Chen, Xingyu; Tong, Qingyi; Zhang, Yonghui; Ren, Hong.
Afiliação
  • Qiao N; Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • An Z; Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Fu Z; Department of Anesthesiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
  • Chen X; Department of Clinical Laboratory, The Central Hospital of Wuhan, Wuhan, China.
  • Tong Q; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: qytong@hust.edu.cn.
  • Zhang Y; Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: zhangyh@mails.tjmu.edu.cn.
  • Ren H; Biobank, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: renhong@hust.edu.cn.
Eur J Pharmacol ; 949: 175717, 2023 Jun 15.
Article em En | MEDLINE | ID: mdl-37054938

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Prognostic_studies Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China